RNA-seq analysis of lung adenocarcinomas reveals different gene expression profiles between smoking and nonsmoking patients
- 720 Downloads
Lung adenocarcinoma is caused by the combination of genetic and environmental effects, and smoking plays an important role in the disease development. Exploring the gene expression profile and identifying genes that are shared or vary between smokers and nonsmokers with lung adenocarcinoma will provide insights into the etiology of this complex cancer. We obtained RNA-seq data from paired normal and tumor tissues from 34 nonsmoking and 34 smoking patients with lung adenocarcinoma (GEO: GSE40419). R Bioconductor, edgeR, was adopted to conduct differential gene expression analysis between paired normal and tumor tissues. A generalized linear model was applied to identify genes that were differentially expressed in nonsmoker and smoker patients as well as genes that varied between these two groups. We identified 2273 genes that showed differential expression with FDR < 0.05 and |logFC| >1 in nonsmoker tumor versus normal tissues; 3030 genes in the smoking group; and 1967 genes were common to both groups. Sixty-eight and 70 % of the identified genes were downregulated in nonsmoking and smoking groups, respectively. The 20 genes such as SPP1, SPINK1, and FAM83A with largest fold changes in smokers also showed similar large and highly significant fold changes in nonsmokers and vice versa, showing commonalities in expression changes for adenocarcinomas in both smokers and nonsmokers for these genes. We also identified 175 genes that were significantly differently expressed between tumor samples from nonsmoker and smoker patients. Gene expression profile varied substantially between smoker and nonsmoker patients with lung adenocarcinoma. Smoking patients overall showed far more complicated disease mechanism and have more dysregulation in their gene expression profiles. Our study reveals pathogenetic differences in smoking and nonsmoking patients with lung adenocarcinoma from transcriptome analysis. We provided a list of candidate genes for further study for disease detection and treatment in both smoking and nonsmoking patients with lung adenocarcinoma.
KeywordsRNA-seq Expression analysis Smoking Lung cancer Lung adenocarcinoma
This research was partially supported by NIH research grant U19CA148127.
Conflict of interest
- 1.Navada S, Lai P, Schwartz AG, Kalemkerian GP. Temporal trends in small cell lung cancer: analysis of the national Surveillance Epidemiology and End-Results (SEER) database [abstract 7082]. J Clin Oncol. 2006;24(18S):384S.Google Scholar
- 6.Sun S, Schiller JH, Gazdar AF. Lung cancer in never smokers—a different disease. Nature. 2007;7:778–90.Google Scholar
- 12.Kim SC, Jung Y, Park J, Cho S, et al. A high-dimensional, deep-sequencing study of lung adenocarcinoma in female never-smokers. PLoS One. 2013;8(2):e55596.Google Scholar
- 13.McCarthy DJ, Chen Y, Smyth GK. Differential expression analysis of multifactor RNA-seq experiments with respect to biological variation. Nucleic Acids Res. 2012;1–10.Google Scholar
- 14.Lazar V, Suo C, Orear C, Oord VJ, et al. Integrated molecular portrait of non-small cell lung cancers. BMC Medical Genomics. 2013;6:53.Google Scholar
- 18.Knight SD, Presto J, Linse S, Johansson J. The BRICHOS domain. Amyloid fibril formation and their relationship. Biochemistry. 2013;52(43):7523–7531.Google Scholar
- 20.Kim SH, Chen G, Jeon C K, Zhao L, Colacino J, et al. Abstract 3124: Smoking effects on CYP24A1 in lung adenocarcinoma: epigenetic changes by smoking. Proceedings: AACR 103rd Annual meeting 2012.Google Scholar
- 22.Li R, Wang H, Bekele BN, Jiang F. Identification of putative oncogenes in lung adenocarcinoma by a comprehensive functional genomic approach. Oncogene. 2005;18:2628–35.Google Scholar
- 23.Choi CGC, Li J, Wang Y, Li L, Zhong L, Ma B, et al. The metalloprotease ADAMTS8 displays antirumor properties through antagonizing EGFR-MEK-ERK signaling and is silenced in cancinomas by CpG methylation. Mol Cancer Res. 2014;12: 228–238.Google Scholar
- 33.Schroeder EB,Welch VL, Couper D, Nieto FJ, Liao D, Rosamond WD, et al. Lung function and incident coronary heart disease: the atherosclerosis risk in communities study. Am J Epidemiol. 2003:158(12):1171–1181.Google Scholar
- 37.Lu Y, Yi Y, Liu P, Wen W, James M, Wang D, et al. Common Human Cancer Genes Discovered by Integrated Gene-Expression Analysis. PLoS ONE. 2007;2(11):e1149.Google Scholar
- 38.Rohrbeck A, Borlak J. Cancer Genomics Identifies Regulatory Gene Networks. Associated with the Transition from Dysplasia to Advanced Lung Adenocarcinomas Induced by c-Raf-1. PLoS One. 2009. doi: 10.1371/journal.pone.0007315.
- 39.Campioni M, Ambrogi V, Pompeo E, Citro G, Castelli M, Spugnini EP, et al. Identification of genes down-regulated during lung cancer progression: A cDNA array study. J Exp Clin Cancer Res. 2008;27(1):38.Google Scholar
- 40.Knudson AG. Antioncogenes and human cancer. Proc Natl Acad Sci USA. 1993;90:10914–10921.Google Scholar
- 43.Chen Y, Liu H, Wu W, Li Y, Li J. Osteopontin genetic variants are associated with overall survival in advanced non-small-cell lung cancer patients and bone metastasis. J Exp Clin Cancer Res. 2013;32(45). doi: 10.1186/1756-9966-32-45.
- 47.Li Y, Dong X, Yin Y, Su Y, Xu Q, et al. BJ-TSA-9, a novel human tumor-specific gene, has potential as a biomarker as a biomarker of lung cancer. Beoplasia. 2005;7(12):1073–1080.Google Scholar
- 48.GDS1348 / 002003020005 / FAM83A / Homo sapiens. Analysis of cultured normal bronchial epithelial cells 4 and 24 hours after exposure to 15 minutes of cigarette smoke in order to better understand molecular impact of tobacco exposure. http://www.ncbi.nlm.nih.gov/geo/gds/profileGraph.cgi?&dataset=A5KYKBJEB4MVOzwuoi&dataset=awhtm-la8vptmyyyxx$&gmin=0.511550&gmax=8.553317&absc=&uid=12856830&gds=1348&idref=002003020005&annot=FAM83A